ICON team recognised for outstanding quality at PharmaTimes awards Dublin, Ireland, February 29th , 2008 – ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that a team from ICON Clinical Research Netherlands has been awarded the PharmaTimes Clinical Research Team of the Year. The PharmaTimes awards, announced at a ceremony in London last night, are designed to recognise and reward excellence in pharmaceutical clinical development. The ICON team was recognised for its outstanding performance over the past year.
In addition to the team accolade, ICON also achieved a bronze award in the Clinical Research Associate of the year category and had sixteen Clinical Research staff short listed as finalists across different categories, the highest number from any organisation.
Alan Morgan, President of ICON Clinical Research, Europe commented: “We are delighted to receive this important industry accolade, as it recognises the contribution that our people have made to the overall success of the company. ICON has established itself as a global service provider with an excellent reputation for quality, which is down to the efforts of our staff. We are very proud of all of our finalists.”
Notes to the Editor
About ICON
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1,900 development projects and over 2,300 consultancy engagements across all major therapeutic areas. ICON currently has approximately 5,600 employees, operating from 67 locations in 37 countries. Further information on the company and on vacancies is available at www.iconplc.com
Back to press releases
In addition to the team accolade, ICON also achieved a bronze award in the Clinical Research Associate of the year category and had sixteen Clinical Research staff short listed as finalists across different categories, the highest number from any organisation.
Alan Morgan, President of ICON Clinical Research, Europe commented: “We are delighted to receive this important industry accolade, as it recognises the contribution that our people have made to the overall success of the company. ICON has established itself as a global service provider with an excellent reputation for quality, which is down to the efforts of our staff. We are very proud of all of our finalists.”
Notes to the Editor
About ICON
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1,900 development projects and over 2,300 consultancy engagements across all major therapeutic areas. ICON currently has approximately 5,600 employees, operating from 67 locations in 37 countries. Further information on the company and on vacancies is available at www.iconplc.com